IRIDEX CORP
IRIXNasdaq
$0.93
↓ -1.7%Jul 17 close · end-of-day
Price
1Y↓ -12.7%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$16.2M
Enterprise Value
$11.6M
P/E
—
P/S
0.3
P/B
3.4
EV/EBITDA
—
PEG
—
FCF Yield
-15.7%
Dividend Yield
—
Revenue (TTM)
$52.6M
Net Income (TTM)
-$3.3M
Free Cash Flow (TTM)
-$2.5M
Gross Margin
36.0%
Operating Margin
-5.1%
Net Margin
-6.2%
ROE
-69.2%
ROIC
-1551.2%
Debt / Equity
—
Net Cash
$4.6M
Return 1Y
-27.6%
Company profile
IRIDEX Corporation provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation systems. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name in 1995.
- CEO
- David I. Bruce
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 120
- Headquarters
- California
- Website
- iridex.com
Management & directors
- Dizon Romeo RChief Financial Officer
- Mercer PatrickPresident and CEO
Roles derived from SEC Form 4 filings.
Earnings
IRIX Q1 2026 Earnings
Period ends 2026-04-04
MetricActualYoY
Revenue$11.8M↓ -0.8%
Diluted EPS-$0.03↓ -70.0%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2021 | FY2022 | FY2022 | FY2023 | FY2024 | FY2026 |
|---|---|---|---|---|---|---|
| Revenue | $36.3M | $53.9M | $57.0M | $51.9M | $48.7M | $52.7M |
| Gross profit | $15.6M | $22.8M | $25.4M | $21.8M | $19.5M | $19.2M |
| Operating income | -$6.6M | -$7.5M | -$7.5M | -$10.0M | -$8.3M | -$2.6M |
| Net income | -$6.3M | -$5.2M | -$7.5M | -$9.6M | -$8.9M | -$4.4M |
| Diluted EPS | -$0.46 | -$0.34 | -$0.47 | -$0.59 | -$0.54 | -$0.26 |
| Operating cash flow | -$3.2M | $8.2M | -$9.5M | -$6.7M | -$7.3M | -$2.1M |
| Free cash flow | -$3.3M | $8.0M | -$9.8M | -$6.9M | -$7.3M | -$2.3M |
| Gross margin | 42.8% | 42.4% | 44.5% | 42.0% | 40.1% | 36.5% |
| Operating margin | -18.1% | -14.0% | -13.2% | -19.3% | -17.1% | -4.9% |
| Net margin | -17.4% | -9.7% | -13.2% | -18.5% | -18.3% | -8.4% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '26 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.6M | $11.6M | $12.7M | $11.9M | $13.6M | $12.5M | $14.7M | $11.8M |
| Gross profit | $5.1M | $4.3M | $5.6M | $5.1M | $4.7M | $4.0M | $5.5M | $4.7M |
| Operating income | -$2.6M | -$1.9M | -$501,000.00 | -$205,000.00 | -$940,000.00 | -$1.4M | -$15,000.00 | -$324,000.00 |
| Net income | -$2.7M | -$1.9M | -$834,538.00 | -$1.7M | -$994,000.00 | -$1.6M | -$184,000.00 | -$524,000.00 |
| Diluted EPS | -$0.16 | -$0.12 | -$0.05 | -$0.10 | -$0.06 | -$0.09 | -$0.01 | -$0.03 |
| Operating cash flow | -$1.3M | -$3.1M | -$1.2M | -$1.1M | -$397,000.00 | -$1.2M | $589,000.00 | -$1.3M |
| Free cash flow | -$1.3M | -$3.1M | -$1.2M | -$1.2M | -$410,000.00 | -$1.2M | $483,000.00 | -$1.4M |
| Gross margin | 40.7% | 37.3% | 44.0% | 42.5% | 34.5% | 32.1% | 37.2% | 40.2% |
| Operating margin | -20.9% | -16.1% | -3.9% | -1.7% | -6.9% | -11.3% | -0.1% | -2.7% |
| Net margin | -21.2% | -16.7% | -6.6% | -14.2% | -7.3% | -12.6% | -1.2% | -4.4% |
Company news
Jun 9, 2026
May 25, 2026
May 20, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-10 | Mercer Patrick· President and CEO | Award | 100,000 | $0.00 | $0.00 | filing |
| 2026-07-10 | Dizon Romeo R· Chief Financial Officer | Award | 30,000 | $0.00 | $0.00 | filing |
| 2026-07-07 | Novel Inspiration International Co., Ltd. | J | 111,997 | — | — | filing |
| 2026-06-13 | Mercer Patrick· President and CEO | Tax withholding | 3,990 | $1.12 | $4,468.80 | filing |
| 2026-06-13 | Dizon Romeo R· Chief Financial Officer | Tax withholding | 2,691 | $1.12 | $3,013.92 | filing |
| 2026-06-12 | Dizon Romeo R· Chief Financial Officer | Buy | 975 | $1.14 | $1,110.14 | filing |
| 2026-06-11 | Dizon Romeo R· Chief Financial Officer | Buy | 1,675 | $1.14 | $1,909.50 | filing |
| 2026-06-08 | Dizon Romeo R· Chief Financial Officer | Buy | 2,400 | $1.12 | $2,688.00 | filing |
| 2026-06-05 | Dizon Romeo R· Chief Financial Officer | Buy | 2,521 | $1.15 | $2,899.15 | filing |
| 2026-06-03 | Dizon Romeo R· Chief Financial Officer | Buy | 2,400 | $1.17 | $2,808.00 | filing |
| 2026-05-26 | Mercer Patrick· President and CEO | Tax withholding | 19,233 | $1.01 | $19,425.33 | filing |
| 2026-05-26 | Dizon Romeo R· Chief Financial Officer | Buy | 5,004 | $1.00 | $5,004.00 | filing |
| 2026-04-01 | Novel Inspiration International Co., Ltd. | J | 87,949 | — | — | filing |
| 2026-03-06 | Dizon Romeo R· Chief Financial Officer | Buy | 1,110 | $1.26 | $1,398.60 | filing |
| 2026-02-17 | Dizon Romeo R· Chief Financial Officer | Buy | 1,200 | $1.31 | $1,572.00 | filing |
| 2026-02-17 | Dizon Romeo R· Chief Financial Officer | Buy | 1,000 | $1.37 | $1,370.00 | filing |
| 2026-02-12 | Dizon Romeo R· Chief Financial Officer | Buy | 1,500 | $1.43 | $2,145.00 | filing |
| 2026-02-10 | Dizon Romeo R· Chief Financial Officer | Buy | 1,000 | $1.46 | $1,460.00 | filing |
| 2026-02-03 | Dizon Romeo R· Chief Financial Officer | Buy | 2,500 | $1.38 | $3,450.00 | filing |
| 2026-01-29 | Dizon Romeo R· Chief Financial Officer | Buy | 1,101 | $1.44 | $1,587.64 | filing |
| 2026-01-28 | Dizon Romeo R· Chief Financial Officer | Buy | 1,300 | $1.46 | $1,898.00 | filing |
| 2026-01-27 | Dizon Romeo R· Chief Financial Officer | Buy | 3,385 | $1.48 | $5,009.46 | filing |
| 2026-01-26 | Dizon Romeo R· Chief Financial Officer | Buy | 1,243 | $1.52 | $1,889.36 | filing |
| 2026-01-23 | Dizon Romeo R· Chief Financial Officer | Buy | 5,221 | $1.48 | $7,716.12 | filing |
| 2026-01-21 | Dizon Romeo R· Chief Financial Officer | Buy | 1,750 | $1.49 | $2,607.50 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.